Call us +49 (0) 761 / 270-51190

Research

Publications

Nickel K, Perlov E, Reisert M, Runge K, Friedel E, Denzel D, Ebert D, Endres D, Domschke K, van Elst LT, Maier S: Altered transcallosal fiber count and volume in high-functioning adults with autism spectrum disorder. Psychiatry Res Neuroimaging 322, 111464; doi: 10.1016/j.pscychresns.2022.111464 (2022).

Endres D, von Zedtwitz K, Matteit I, Bünger I, Foverskov-Rasmussen H, Runge K, Feige B, Schlump A, Maier S, Nickel K, Berger B, Schiele MA, Cunningham JL, Domschke K, Prüss H, van Elst LT: Spectrum of Novel Anti–Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders. Biol Psychiatry 92(4), 261-274; doi: 10.1016/j.biopsych.2022.02.010 (2022).

Dudek M, Lohr K, Donakonda S, Baumann T, Lüdemann M, Hegenbarth S, Dübbel L, Eberhagen C, Michailidou S, Yassin A, Prinz M, Popper B, Rose-John S, Zischka H, Knolle PA: IL-6-induced FOXO1 activity determines the dynamics of metabolism in CD8 T cells cross-primed by liver sinusoidal endothelial cells. Cell Rep 38(7):110389; doi: 10.1016/j.celrep.2022.110389 (2022).

Endres D, Lüngen E, Hasan A, […], Domschke K, […] van Elst LT: Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany. Molecular Psychiatry 27, 1479–1489 (2022).

Czeh M, Stäble S, Krämer S, Tepe L, Talyan S, Carrelha J, Meng Y, Heitplatz B, Schwabenland M, Milsom MD, Plass C, Prinz M, Schlesner M, Andrade-Navarro MA, Nerlov C, Jacobsen SEW, Lipka DB, Rosenbauer F: DNMT1 Deficiency Impacts on Plasmacytoid Dendritic Cells in Homeostasis and Autoimmune Disease. J Immunol 208(2), 358-370 (2022).

Kleis P, Paschen E, Häussler U, Bernal Sierra YA, Haas CA: Long-term in vivo characterization and application of a novel potassium channel-based optogenetic silencer in the healthy and epileptic mouse hippocampus. BMC Biology 20, 18 (2022).

Ebrahimi A, Korshunov A, Reifenberger G, Capper D, Felsberg J, Trisolini E, Pollo B, Calatozzolo C, Prinz M, Staszewski O, Schweizer L, Schittenhelm J, Harter PN, Paulus W, Thomas C, Kohlhof‑Meinecke P, Seiz‑Rosenhagen M, Milde T, Casalini BM, Suwala A, Wefers AK, Reinhardt A, Sievers P, Kramm CM, Etminam N, Unterberg A, Wick W, Herold‑Mende C, Sturm D, Pfister SM, Sill M, Jones DTW, Schrimpf D, Reuss DE, Aldape K, Abdullaev Z, Sahm F, von Deimling A and Stichel D: Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. Acta Neuropathol Commun 10(1):5 (2022).

Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL; ECNP Network Immuno-NeuroPsychiatry; Domschke K, van Elst LT, Schiele MA: Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype? Transl Psychiatry 12(1), 5; doi: 10.1038/s41398-021-01700-4 (2022).

Neidert N, Strähle J, Erny D, Sacalean V, El Rahal A, Steybe D, Schmelzeisen R, Vlachos A, Reinacher PC, Coenen VA, Mizaikoff B, Heiland DH, Prinz M, Beck J, Schnell O: Stimulated Raman histology in the neurosurgical workflow of a major European neurosurgical center – part A. Neurosurg Rev; doi: 10.1007/s10143-021-01712-0 (2021).

Chhatbar, C, Prinz M: From shape to contents: heterogeneity of CNS glial cells. Acta Neuropathol 143(2), 123-124 (2022).

d’Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mezö C, Erny D, Sebastian Monasor L, Liebscher S, Ravi VM, Joseph K, Schnell O, Kierdorf K, Staszewski O, Tahirovic S, Prinz M, Meyer-Luehmann M: Microglia contribute to the propagation of Aβ into unaffected brain tissue. Nat Neurosci; doi: 10.1038/s41593-021-00951-0 (2021).

Kettwig M, Ternka K, Prinz M, Nessler S, Gärtner J: Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy. Nature Communications 12, 6530 (2021).

Vestring S, Domschke K, Normann K: Ketamin und andere N-Methyl-DAspartat- Rezeptor-Modulatoren zur Behandlung der Depression. Der Nervenarzt; doi 10.1007/s00115-021-01221-x (2021).

Cauwels A, van Lint S, Rogge E, Verhee A, van den Eeckhout B, Pang S, Prinz M, Kley N, Uzé G, Tavernier J: Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE. Scientific Reports 11, 21575 (2021).

Erny D, Dokalis N, Mezö C, Castoldi A, Mossad O, Staszewski O, Frosch M, Villa M, Fuchs V, Mayer A, Neuber J, Sosat J, Tholen S, Schilling O, Vlachos A, Blank T, Gomez de Agüero M, Macpherson AJ, Pearce EJ, Prinz M: Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab 33(11); 2260-2276.e7 (2021).

Schneider M, Vollmer L, Potthoff A-L, Ravi VM, Evert BO, Rahman MA, Sarowar S, Kueckelhaus J, Will P, Zurhorst D, Joseph K, Maier JP, Neidert N, d’Errico P, Meyer-Luehmann M, Hofmann UG, Dolf A, Salomoni P, Güresir E, Enger PØ, Chekenya M, Pietsch T, Schuss P, Schnell O, Westhoff MA, Beck J, Vatter H, Waha A, Herrlinger U, Heiland DH: Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma. Neuro Oncol;23(11):1885-1897. doi: 10.1093/neuonc/noab092 (2021).